⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TLX News
Telix Pharmaceuticals Limited American Depositary Shares
Levi & Korsinsky Notifies Telix Pharmaceuticals Ltd. (TLX) Shareholders of Class Action Lawsuit and January 9, 2026 Deadline
accessnewswire.com
TLX
TLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
TLX
Pomerantz LLP Issues Reminder to Investors in Telix Pharmaceuticals Limited of Class Action Filing – TLX
accessnewswire.com
TLX
Securities Lawsuit Alert: Telix Pharmaceuticals Ltd. (TLX) - Contact Levi & Korsinsky Before January 9, 2026
accessnewswire.com
TLX
21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures
globenewswire.com
TLX
Join Class Action to Recover Losses From Telix Pharmaceuticals Ltd. (TLX) - Contact Levi & Korsinsky Before January 9, 2026
accessnewswire.com
TLX
TLX Deadline: TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm
prnewswire.com
TLX
TLX DEADLINE NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TLX
accessnewswire.com
TLX
Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately
prnewswire.com
TLX
Levi & Korsinsky Notifies Telix Pharmaceuticals Ltd. (TLX) Shareholders of Class Action Lawsuit And January 9, 2026 Deadline
accessnewswire.com
TLX